1-3 of 3
Daniel Johnson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

MiRNA29B Induces Fetal Hemoglobin through Targeting DNMT3 and MYB in Vitro and In Vivo in Preclinical Townes Sickle Cell Mice

Ernestine Amos-Abanyie, Chithra Palani, Alana Smith, Qingqing Gu, Ugochi Ogu, Daniel Johnson, Umapathy N Siddaramappa, Betty S. Pace, Athena Starlard-Davenport
Journal: Blood
Blood (2022) 140 (Supplement 1): 2496–2497.
https://doi.org/10.1182/blood-2022-165597
Published: 2022
Journal Articles

A Phase II Clinical Trial of Rituximab, Cyclophosphamide, Bortezomib, and Dexamethasone (R-CyBor-D) in Relapsed Low Grade and Mantle Cell Lymphoma

Allison C. Rosenthal, DO, Amylou Constance Dueck, PhD, Katherine Gano, MS, Craig Nichols, Daniel Johnson, Angela Toro, NP, Sravan Nagi Reddy, James L Slack, MD, Jose F Leis, MD PhD, Donald W. Northfelt, MD, P. Leif Bergsagel, MD, Rodger Tiedemann, MBChB, PhD, Patrick B. Johnston, MD PhD, Thomas M Habermann, MD, Thomas E. Witzig, MD, Craig B. Reeder, MD
Journal: Blood
Blood (2014) 124 (21): 4410.
https://doi.org/10.1182/blood.V124.21.4410.4410
Published: 2014
Journal Articles

A Phase I/II Combination Of RAD001 (Everolimus) and Lenalidomide For Relapsed Lymphoid Malignancy: Phase I Results

Craig Reeder, MD, Amylou Constance Dueck, PhD, Katherine Gano, Craig Nichols, Angela Toro, NP, Daniel Johnson, Patrick B. Johnston, Thomas M. Habermann, Jose F Leis, MD, PhD, Grzegorz S. Nowakowski, MD, Joseph Mikhael, MD, Joseph Colgan, Luis F. Porrata, MD, James L Slack, MD, Stephen M Ansell, Thomas E Witzig
Journal: Blood
Blood (2013) 122 (21): 4350.
https://doi.org/10.1182/blood.V122.21.4350.4350
Published: 2013